News

BMI Extremes Tied to Mortality in Diabetes


 

From the annual meeting of the American Diabetes Association

ORLANDO — The adage “Moderation in all things” may directly apply to longevity for people with diabetes, according to a national epidemiologic study from Scotland.

The study of more than 150,000 Scots with type 2 diabetes found that those with extremely high—and extremely low—body mass index were up to twice as likely to die during follow-up as were those with more moderate BMIs.

The study cannot draw any causal links between a moderate BMI and a decrease in mortality, Dr. Jeremy Walker said at the meeting. But it does raise intriguing questions about maintaining a healthy body weight that avoids becoming either over- or underweight.

“Elevated mortality in higher BMI ranges carries urgent and widely recognized public health implications,” said Dr. Walker of the University of Edinburgh Centre for Population Health Sciences. “Elevated BMI is associated with adverse effects on blood pressure, lipid levels, cardiovascular disease risk, glucose metabolism, and cancer.”

While plausible explanations for the relationship between high BMI and death have long existed, explaining the association of low BMI with death is more problematic, Dr. Walker said in an interview. “Low BMI may actually be a consequence of preexisting illness (as is the case in many cancers and much respiratory disease) rather than a cause.”

However, he said, few investigators have drawn attention to the relationship between mortality and the lower range of BMI. One major study, the Prospective Studies Collaboration (PSC), observed a significant relationship between low-normal BMI and all-cause mortality.

The PSC examined the relation between all-cause mortality and baseline BMI in almost 1 million subjects who had been included in 57 prospective studies and followed for a mean of 8 years. The investigators found a very strong U-shaped mortality curve linked with BMI. For both genders, the lowest mortality occurred at 22.5-25 kg/m

Dr. Walker and his coworkers examined the relationship between mortality and BMI in 150,396 patients with type 2 diabetes in the Scottish Care Information Diabetes Collaboration. An initial recording of patients' BMI was linked to national mortality records through 2007, with a mean follow-up of 6 years. The analysis was adjusted for age and socioeconomic status.

There were 81,004 males in the cohort, 13,059 of whom had died by 2007. There were 69,392 females, 11,179 of whom had died by the end of the study.

The mortality and BMI data showed a strong U-shaped curve, with the lowest mortality in the BMI range of 25 to less than 35. For men with a BMI of 15 to less than 20, the risk of death was almost double that of men in the 25-35 range. The risk of death was 1.5 times increased for men with a BMI of 20 to less than 22.5.

Elevation of risk also was observed for men with a BMI of above 35 to 45 kg/m

Women faced similar risks. Women with the lowest BMI of 15 to less than 20 kg/m

The study was sponsored by the Scottish Health Informatics Programme, a collaboration funded by the Wellcome Trust. Dr. Walker had no financial declarations regarding the study.

'Low BMI may actually be a consequence of preexisting illness … rather than a cause' of mortality.

Source DR. WALKER

Recommended Reading

Snoring Linked to Gestational Diabetes Risk : Habitual snorers had significantly higher blood glucose levels after a 1-hour tolerance test.
MDedge Endocrinology
White Rice Raised Diabetes Risk 17%, Over Brown Rice
MDedge Endocrinology
Innovations Steadily Advance Artificial Pancreas
MDedge Endocrinology
ADA, ACS Spotlight Diabetes-Cancer Links
MDedge Endocrinology
Metformin Cut Deaths in Patients at Risk for CVD
MDedge Endocrinology
Investigational Insulin Analogue Effective, Safe in Early Trials
MDedge Endocrinology
Pump+Sensor Beats Daily Shots to Trim HbA1c : Gains in glucose control must be weighed against demands the high-tech pumps place on patients.
MDedge Endocrinology
Gestational Diabetes Flags Elevated Risk for Hypertension
MDedge Endocrinology
Tapentadol ER Effective for Neuropathic Pain : The investigational analgesic also performed well in treating chronic nociceptive pain of osteoarthritis.
MDedge Endocrinology
Type 1 Survival Rates Improve, Though Challenges Remain
MDedge Endocrinology